Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 76–90 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-162 Alpha-2-Macroglobulin (A2M) Test This diagnostic test evaluates the concentration of Alpha-2-Macroglobulin, a protein produced by the liver, in the serum.	Serum (peripheral blood)	10 days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Alpha-2-Macroglobulin protein levels", "Serum protease inhibition activity"] Parameters [{"name": "Alpha-2-Macroglobulin", "reference_range": null}] Preparation ["Observe an overnight fast of 8–12 hours.", "Avoid vigorous exercise for 24 hours before the blood draw.", "Stay hydrated with water only."] Indications ["Suspected hepatic cirrhosis", "Monitoring liver fibrosis progression", "Evaluation of nephrotic syndrome", "Assessment of protein-losing nephropathies"] Measurement technique Confirm with laboratory Codes LOINC: 1884-6 ICD-10: R79.89 Clinical summary This diagnostic test evaluates the concentration of Alpha-2-Macroglobulin, a protein produced by the liver, in the serum.
TEST-535 Alpha-Aminoadipic Aciduria Test This diagnostic test evaluates the concentration of alpha-aminoadipic acid in urine and plasma to screen for deficiencies in lysine, tryptophan, and hydroxylysine catabolism.	Urine (random or timed) & Plasma (EDTA)	2 weeks from sample receipt	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Alpha-aminoadipic acid concentration", "Lysine, tryptophan, and hydroxylysine catabolism pathway"] Parameters [{"name": "Alpha-Aminoadipic Acid", "reference_range": null}] Preparation ["Fasting for 8–12 hours (water only)", "Avoid high-protein meals the day before", "Continue prescribed medications unless advised otherwise by physician"] Indications ["Screening for antiquitin deficiency", "Risk stratification for urological stones", "Monitoring therapeutic interventions", "Genetic counseling guidance"] Measurement technique Confirm with laboratory Codes LOINC: 35167-5 ICD-10: E72.3 Clinical summary This diagnostic test evaluates the concentration of alpha-aminoadipic acid in urine and plasma to screen for deficiencies in lysine, tryptophan, and hydroxylysine catabolism.
TEST-6106 ALPL Gene Hypophosphatasia (Infantile) NGS Test This test identifies mutations in the ALPL gene associated with infantile hypophosphatasia.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ALPL gene mutations", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["No special preparation such as fasting is required"] Indications ["Suspected infantile hypophosphatasia", "Low alkaline phosphatase levels", "Severe metabolic bone disorder"] Measurement technique Confirm with laboratory Codes LOINC: 82163-2 ICD-10: E83.30 Clinical summary This test identifies mutations in the ALPL gene associated with infantile hypophosphatasia.
TEST-3782 ALS2 Gene (Amyotrophic Lateral Sclerosis Type 2, Juvenile) Genetic Test This genetic test evaluates the ALS2 gene for pathogenic variants associated with juvenile-onset amyotrophic lateral sclerosis (JALS).	Peripheral Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ALS2 gene", "Full coding region analysis"] Parameters [] Preparation ["No specific fasting required.", "Inform phlebotomist of any bleeding disorders or anticoagulant use."] Indications ["Suspicion of juvenile-onset amyotrophic lateral sclerosis (JALS)", "Family history of JALS", "Genetic risk assessment for motor neuron disease"] Measurement technique Confirm with laboratory Codes LOINC: 29527-8 ICD-10: G12.21 Clinical summary This genetic test evaluates the ALS2 gene for pathogenic variants associated with juvenile-onset amyotrophic lateral sclerosis (JALS).
TEST-5528 ALS2 Gene Primary Lateral Sclerosis, Juvenile Genetic Test This test identifies pathogenic variants in the ALS2 gene, which are the definitive cause of juvenile primary lateral sclerosis (JPLS) and infantile-onset ascending hereditary spas...	Whole Blood (EDTA), Extracted DNA, or FTA Card	21–28 Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ALS2 gene", "Copy number variations (CNV) in the ALS2 gene"] Parameters [{"name": "ALS2 Gene Sequencing", "reference_range": "No pathogenic variants detected"}, {"name": "Copy Number Variation (CNV) Analysis", "reference_range": "No pathogenic CNVs detected"}] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected diagnosis of Juvenile Primary Lateral Sclerosis (JPLS)", "Suspected diagnosis of Infantile-Onset Ascending Hereditary Spastic Paralysis (IAHSP)", "Family history of JPLS or IAHSP", "Genetic counseling for families with affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 90202-2 ICD-10: G12.21 Clinical summary This test identifies pathogenic variants in the ALS2 gene, which are the definitive cause of juvenile primary lateral sclerosis (JPLS) and infantile-onset ascending hereditary spastic paralysis (IAHSP).
TEST-2829 ALX4 Gene (Frontonasal Dysplasia Type 2) Genetic Test This test identifies pathogenic variants in the ALX4 gene associated with Frontonasal Dysplasia Type 2 (FND2). It utilizes Next-Generation Sequencing (NGS) to provide comprehensive...	Whole Blood (Peripheral) or FTA Card Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ALX4 gene"] Parameters [] Preparation [] Indications ["Confirmation of clinical dysmorphology findings", "Guiding craniofacial surgical planning"] Measurement technique Confirm with laboratory Codes LOINC: 87611-7 ICD-10: Q75.8 Clinical summary This test identifies pathogenic variants in the ALX4 gene associated with Frontonasal Dysplasia Type 2 (FND2). It utilizes Next-Generation Sequencing (NGS) to provide comprehensive analysis.
TEST-5407 AMBN Gene Amelogenesis Imperfecta Type 1F Genetic Test This genetic test evaluates the AMBN gene for variants causing Amelogenesis Imperfecta Type 1F.	Peripheral whole blood (3–5 mL EDTA) or buccal swab	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AMBN gene variants", "Hypoplastic/hypomaturation type 1F amelogenesis imperfecta"] Parameters [] Preparation [] Indications ["Suspected diagnosis of Amelogenesis Imperfecta Type 1F", "Family history of Amelogenesis Imperfecta", "Genetic counselling for dental conditions"] Measurement technique Confirm with laboratory Codes LOINC: 94302-5 ICD-10: K00.5 Clinical summary This genetic test evaluates the AMBN gene for variants causing Amelogenesis Imperfecta Type 1F.
TEST-3384 AMHR2 Gene (Persistent Mullerian Duct Syndrome Type 2) Genetic Test This genetic test identifies pathogenic variants in the AMHR2 gene, confirming a diagnosis of Persistent Mullerian Duct Syndrome type 2 (PMDS) in individuals with a 46,XY karyotype...	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AMHR2 gene variants", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No fasting required", "Detailed family pedigree required prior to collection"] Indications ["Diagnosis of Persistent Mullerian Duct Syndrome type 2 (PMDS)", "Evaluation of 46,XY difference of sex development", "Infertility evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 21659-2 ICD-10: Q55.8 Clinical summary This genetic test identifies pathogenic variants in the AMHR2 gene, confirming a diagnosis of Persistent Mullerian Duct Syndrome type 2 (PMDS) in individuals with a 46,XY karyotype.
TEST-172 Amikacin Therapeutic Drug Monitoring Test This test measures the concentration of amikacin in the blood to guide dosing adjustments.	Serum	2–3 weeks	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Amikacin Concentration", "Trough Level (lowest concentration)", "Peak Level (highest concentration)"] Parameters [{"name": "Amikacin Trough Level", "reference_range": "Typically 5–10 µg/mL (Consult lab for specific range)"}, {"name": "Amikacin Peak Level", "reference_range": "Typically 30–60 µg/mL (Consult lab for specific range)"}] Preparation ["Collect trough sample immediately before the next dose.", "Collect peak sample 30-60 minutes after IV infusion or 60 minutes after intramuscular injection.", "Follow physician's exact timing instructions."] Indications ["Monitoring patients on amikacin therapy", "Optimising dosage in severe infections", "Minimising risk of nephrotoxicity and ototoxicity", "Patients with impaired renal function"] Measurement technique Confirm with laboratory Codes LOINC: 3392-1 ICD-10: Z51.81 Clinical summary This test measures the concentration of amikacin in the blood to guide dosing adjustments.
TEST-182 Amino Acid Non-Ketotic Hyperglycinemia Panel Quantitative CSF & Plasma Test This diagnostic test evaluates glycine levels in CSF and plasma to confirm or rule out non-ketotic hyperglycinemia (NKH).	Cerebrospinal Fluid (CSF) and EDTA Plasma	3 Working Days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Glycine concentration in Cerebrospinal Fluid (CSF)", "Glycine concentration in Plasma", "CSF-to-plasma glycine ratio"] Parameters [{"name": "Glycine (CSF)", "reference_range": "< 10 µmol/L"}, {"name": "Glycine (Plasma)", "reference_range": null}, {"name": "CSF-to-Plasma Glycine Ratio", "reference_range": "< 0.08"}] Preparation ["Supervised fast of four hours prior to collection", "Continue all antiepileptic medications unless directed otherwise", "Provide complete drug history including dosages and timing"] Indications ["Suspected non-ketotic hyperglycinemia (NKH)", "Neonatal seizures of unknown origin", "Neonatal hypotonia", "Apneic episodes in neonates"] Measurement technique Confirm with laboratory Codes LOINC: 23673-3 ICD-10: E72.51 Clinical summary This diagnostic test evaluates glycine levels in CSF and plasma to confirm or rule out non-ketotic hyperglycinemia (NKH).
TEST-175 Amino Acid Quantitative CSF Full Panel (45 Amino Acids) Test This diagnostic test evaluates the quantitative levels of 45 amino acids in cerebrospinal fluid (CSF). It is used to identify neurometabolic disorders affecting the central nervous...	Cerebrospinal Fluid (CSF)	3 working days	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Quantitative levels of 45 amino acids", "Central nervous system metabolism"] Parameters [{"name": "Alanine", "reference_range": null}, {"name": "Arginine", "reference_range": null}, {"name": "Asparagine", "reference_range": null}, {"name": "Aspartic Acid", "reference_range": null}, {"name": "Cysteine", "reference_range": null}, {"name": "Glutamic Acid", "reference_range": null}, {"name": "Glutamine", "reference_range": null}, {"name": "Glycine", "reference_range": null}, {"name": "Histidine", "reference_range": null}, {"name": "Isoleucine", "reference_range": null}, {"name": "Leucine", "reference_range": null}, {"name": "Lysine", "reference_range": null}, {"name": "Methionine", "reference_range": null}, {"name": "Phenylalanine", "reference_range": null}, {"name": "Proline", "reference_range": null}, {"name": "Serine", "reference_range": null}, {"name": "Threonine", "reference_range": null}, {"name": "Tryptophan", "reference_range": null}, {"name": "Tyrosine", "reference_range": null}, {"name": "Valine", "reference_range": null}] Preparation ["No dietary fasting required", "Inform doctor of all medications, especially anticoagulants and antiplatelet agents"] Indications ["Suspected neurometabolic disorder", "Diagnosis of inborn errors of amino acid metabolism", "Evaluation of CNS metabolic dysfunction"] Measurement technique Confirm with laboratory Codes LOINC: 48697-8 ICD-10: E72.9 Clinical summary This diagnostic test evaluates the quantitative levels of 45 amino acids in cerebrospinal fluid (CSF). It is used to identify neurometabolic disorders affecting the central nervous system.
TEST-189 Amino Acids Qualitative Urine & Plasma Test This test evaluates for abnormal amino acid patterns in urine and plasma, indicative of metabolic disorders or renal issues.	Plasma (green-top sodium heparin) & Urine (midstream, first morning)	2 working days (Mon/Wed/Fri batch)	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Amino acid levels in urine", "Amino acid levels in plasma"] Parameters [] Preparation ["Collect first morning urine midstream in a sterile container; refrigerate immediately.", "Plasma sample requires a 2 mL blood sample drawn into a green-top sodium heparin tube after an overnight fast (4-6 hours for infants).", "List all medications, supplements, and special diets on the request form.", "Do not stop any medications without your doctor’s approval."] Indications ["Suspected inborn errors of metabolism", "Investigation of renal transport defects", "Assessment of metabolic stress", "Pediatric metabolic screening", "Nephrology workup", "Sports medicine evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 30911-0 ICD-10: E72.9 Clinical summary This test evaluates for abnormal amino acid patterns in urine and plasma, indicative of metabolic disorders or renal issues.
TEST-197 Amino Acids Quantitative Panel (Urine & Plasma, 45 Analytes) Test This test quantifies 45 amino acids in urine and plasma to screen for and diagnose inborn errors of metabolism.	Urine (first morning) + Plasma (sodium heparin)	3 working days from sample receipt (Mon/Wed collection)	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Concentration of 45 amino acids in urine", "Concentration of 45 amino acids in plasma"] Parameters [{"name": "Amino Acids", "reference_range": "Specific reference ranges vary; provided in the report"}] Preparation ["Collect first morning urine in a sterile container without preservatives", "Provide a plasma sample from a sodium heparin green-top tube", "Requires an overnight fast", "Include clinical details and drug history with specimens", "Do not discontinue or alter prescribed medication before consulting physician"] Indications ["Screening for inborn errors of metabolism (IEMs)", "Diagnosis of IEMs like PKU, MSUD, homocystinuria, tyrosinemia, urea cycle disorders", "Metabolic work-up in neonates, children, and adults"] Measurement technique Confirm with laboratory Codes LOINC: 24320-4 ICD-10: Z13.228, R79.8 Clinical summary This test quantifies 45 amino acids in urine and plasma to screen for and diagnose inborn errors of metabolism.
TEST-204 Amino Acids Quantitative Plasma Full Panel (45 Analytes) Test This test quantitatively measures 45 amino acids in plasma to aid in the diagnosis of inherited metabolic disorders and assess nutritional status.	Plasma (Peripheral Venous Blood)	3 working days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["45 amino acids (proteinogenic and non-proteinogenic)", "Amino acid concentrations in plasma"] Parameters [{"name": "Alanine", "reference_range": null}, {"name": "Arginine", "reference_range": null}, {"name": "Asparagine", "reference_range": null}, {"name": "Aspartate", "reference_range": null}, {"name": "Cysteine", "reference_range": null}, {"name": "Glutamate", "reference_range": null}, {"name": "Glutamine", "reference_range": null}, {"name": "Glycine", "reference_range": null}, {"name": "Histidine", "reference_range": null}, {"name": "Isoleucine", "reference_range": null}, {"name": "Leucine", "reference_range": null}, {"name": "Lysine", "reference_range": null}, {"name": "Methionine", "reference_range": null}, {"name": "Phenylalanine", "reference_range": null}, {"name": "Proline", "reference_range": null}, {"name": "Serine", "reference_range": null}, {"name": "Threonine", "reference_range": null}, {"name": "Tryptophan", "reference_range": null}, {"name": "Tyrosine", "reference_range": null}, {"name": "Valine", "reference_range": null}] Preparation ["Fasting period of 4–6 hours recommended.", "Provide a complete list of all medications, supplements, and recent dietary habits.", "Inform physician about pregnancy or breastfeeding status."] Indications ["Diagnosis of inborn errors of metabolism (IEMs)", "Nutrigenomics", "Elite sports monitoring", "Nutritional assessment"] Measurement technique Confirm with laboratory Codes LOINC: 53152-8 ICD-10: E70.9, E71.0, E72.9 Clinical summary This test quantitatively measures 45 amino acids in plasma to aid in the diagnosis of inherited metabolic disorders and assess nutritional status.
TEST-187 Amino Acids, Maple Syrup Urine Disease (MSUD) Panel (Plasma) Test This diagnostic test evaluates plasma levels of branched-chain amino acids (leucine, isoleucine, valine) to identify imbalances characteristic of Maple Syrup Urine Disease (MSUD).	Plasma (Peripheral Blood)	3 working days	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Leucine", "Isoleucine", "Valine"] Parameters [{"name": "Leucine", "reference_range": null}, {"name": "Isoleucine", "reference_range": null}, {"name": "Valine", "reference_range": null}] Preparation ["No fasting is needed.", "Inform the laboratory of all medications and clinical details.", "Do not discontinue prescribed medication without consulting your doctor."] Indications ["Suspected Maple Syrup Urine Disease (MSUD)", "Monitoring dietary therapy for MSUD", "Evaluating metabolic crises"] Measurement technique Confirm with laboratory Codes LOINC: 51063-6 ICD-10: E71.0 Clinical summary This diagnostic test evaluates plasma levels of branched-chain amino acids (leucine, isoleucine, valine) to identify imbalances characteristic of Maple Syrup Urine Disease (MSUD).

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories